Displaying drugs 6526 - 6550 of 8039 in total
Teprasiran
Teprasiran is under investigation in clinical trial NCT03510897 (QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery).
Investigational
Matched Description: … Teprasiran is under investigation in clinical trial NCT03510897 (QPI-1002 Phase 3 for Prevention of Major …
RAPA-501-Allo
RAPA-501-ALLO is composed of T-cells extracted from healthy volunteers; these cells are then reprogrammed ex vivo in a process that involves de-differentiation and re-differentiation.
Investigational
Matched Description: … RAPA-501-ALLO is composed of T-cells extracted from healthy volunteers; these cells are then reprogrammed …
TERN-101
TERN-101 is under investigation in clinical trial NCT04328077 (LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-cirrhotic Non-alcoholic Steatohepatitis (NASH)).
Investigational
Matched Description: … clinical trial NCT04328077 (LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of …
Gontivimab
Gontivimab is under investigation in clinical trial NCT03468829 (Efficacy and Safety of ALX-0171 in Adult Hematopoietic Stem Cell Transplant (HSCT) Recipients Who Present With Respiratory Syncytial Virus (RSV) Infection).
Investigational
Matched Description: … Gontivimab is under investigation in clinical trial NCT03468829 (Efficacy and Safety of ALX-0171 in Adult …
Favezelimab
Favezelimab is under investigation in clinical trial NCT04626479 (Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)).
Investigational
Matched Description: … Favezelimab is under investigation in clinical trial NCT04626479 (Substudy 03A: A Study of Immune and …
KITE-585
KITE-585 is an autologous, fully-human anti-B cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T cell therapy. It is being investigated in the treatment of multiple myeloma.
Investigational
Matched Description: … It is being investigated in the treatment of multiple myeloma. …
BN‐Brachyury vaccine
BN‐Brachyury vaccine is a novel prime‐boost therapeutic cancer immunotherapy. It is composed of the MVA-BN-brachyury-TRICOM vaccine and the fowlpox virus(FPV)‐Brachyury booster vaccine.
Investigational
Matched Description: … It is composed of the [MVA-BN-brachyury-TRICOM vaccine] and the fowlpox virus(FPV)‐Brachyury booster …
Eftansomatropin alfa
Eftansomatropin alfa (GX-H9) comprises a recombinant human growth hormone fused to hyFc, a synthetic hybrid Fc fragment. It is under investigation for the treatment of growth hormone deficiency.
Investigational
Matched Description: … [L48275] It is under investigation for the treatment of growth hormone deficiency. …
HMI-203
HMI-203 is an investigational gene therapy developed by Homology Medicines, Inc. It consists of a recombinant adeno-associated virus (AAV) serotype HSC15 (rAAVHSC15) encoding human iduronate-2-sulfatase (hIDS).
Investigational
Matched Description: … It consists of a recombinant adeno-associated virus (AAV) serotype HSC15 (rAAVHSC15) encoding human iduronate …
Eldecalcitol
Eldecalcitol (ED-71), a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis. Eldecalcitol, effectively and safely increased lumbar and hip bone mineral density (BMD) in osteoporotic patients who also received vitamin D3 supplementation.
Investigational
Matched Description: … in an estrogen-deficient rat model of osteoporosis. ... Eldecalcitol (ED-71), a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol …
DP-b99
DP-b99 is a newly developed lipophilic, cell permeable derivative of BAPTA (1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid), that is under development as a neuroprotectant for the potential treatment of stroke, head trauma and neurological damage associated with coronary artery bypass graft.
Investigational
Matched Description: … DP-b99 is a newly developed lipophilic, cell permeable derivative of BAPTA (1,2-bis(2-aminophenoxy)ethane-N ... N',N'-tetraacetic acid), that is under development as a neuroprotectant for the potential treatment of …
Norvaline
Norvaline is an isomer of the more common amino acid valine.
Experimental
Matched Description: … Norvaline is an isomer of the more common amino acid valine. …
BMS-690514
BMS-690514 has been investigated for the treatment of Breast Cancer.
Investigational
Matched Description: … BMS-690514 has been investigated for the treatment of Breast Cancer. …
E-6201
E6201 has been investigated for the treatment of Chronic Plaque Psoriasis.
Investigational
Matched Description: … E6201 has been investigated for the treatment of Chronic Plaque Psoriasis. …
Carnosine
Carnosine has been investigated for the treatment of Gulf War Illness.
Investigational
Matched Description: … Carnosine has been investigated for the treatment of Gulf War Illness. …
Fedovapagon
Fedovapagon has been used in trials studying the treatment of Nocturia.
Investigational
Matched Description: … Fedovapagon has been used in trials studying the treatment of Nocturia. …
Arhalofenate
Arhalofenate has been investigated for the treatment of Gout and Hyperuricemia.
Investigational
Matched Description: … Arhalofenate has been investigated for the treatment of Gout and Hyperuricemia. …
Tegobuvir
Tegobuvir has been investigated for the treatment of Hepatitis C, Chronic.
Investigational
Matched Description: … Tegobuvir has been investigated for the treatment of Hepatitis C, Chronic. …
Vistusertib
Vistusertib is under investigation for the treatment of Advanced Gastric Adenocarcinoma.
Investigational
Matched Description: … Vistusertib is under investigation for the treatment of Advanced Gastric Adenocarcinoma. …
Vosaroxin
Vosaroxin is under investigation for the treatment of Leukemia, Myeloid, Acute.
Investigational
Matched Description: … Vosaroxin is under investigation for the treatment of Leukemia, Myeloid, Acute. …
Vanutide cridificar
Vanutide cridificar has been investigated for the treatment of Alzheimer Disease.
Investigational
Matched Description: … Vanutide cridificar has been investigated for the treatment of Alzheimer Disease. …
Cordycepin
Cordycepin has been used in trials studying the treatment of Leukemia.
Investigational
Matched Description: … Cordycepin has been used in trials studying the treatment of Leukemia. …
Dalcetrapib
Dalcetrapib is under investigation for the treatment of Acute Coronary Syndrome.
Investigational
Matched Description: … Dalcetrapib is under investigation for the treatment of Acute Coronary Syndrome. …
Zicronapine
Zicronapine has been used in trials studying the treatment of Schizophrenia.
Investigational
Matched Description: … Zicronapine has been used in trials studying the treatment of Schizophrenia. …
Defactinib
Defactinib has been investigated for the treatment of Malignant Pleural Mesothelioma.
Investigational
Matched Description: … Defactinib has been investigated for the treatment of Malignant Pleural Mesothelioma. …
Displaying drugs 6526 - 6550 of 8039 in total